4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000039
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $84.26 ($1,263,912)
- CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-23 | Option exercise 10b5-1 | +15,000 | $2.03 | $30,450 | 493,888 | D: show line 1 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-23 | Sale 10b5-1 | −5,718 | $83.83 | $479,323 | 488,170 | D: show line 2 in the form |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-23 | Sale 10b5-1 | −9,282 | $84.53 | $784,589 | 478,888 | D: show line 3 in the form |
| Open-market sales · 15,000 sh · avg $84.26 · $1,263,912 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-07-23 | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 182,327 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1721857439.xml…